4,4,5,5-Tetramethyl-2-(2,3,5-trifluorophenyl)-1,3,2-dioxaborolane, 98%, 250mg

DBD-ED [=4-(N,N-Dimethylaminosulfonyl)-7-(2-aminoethylamino)-2,1,3-benzoxadiazole] [for HPLC Labeling]100mg

(Z)-N-(1-Chloro-3-oxo-1-phenyl-3-(piperidin-1-yl)prop-1-en-2-yl)benzamide, 95.0%, 250mg

3-Ethylpentanoic acid, 95+%, 250mg

4-Bromo-N,N,3-trimethylaniline>98.0%(GC)(T)5g

3,5-Dibromo-N,N-dimethylpyrazinamine, 95.0%, 5g

4-Cyano-1-formylpiperidine, 95.0%, 1g

Ammonium chloride, min. 99%, cryst., 1 kg, plastic packaging.

1,3-Dimethyl-piperidin-4-one, 99.0%, 5g

1-((2-(4-CHLOROPHENYL)-4,4-DIMETHYLCYCLOHEX-1-ENYL)METHYL)PIPERAZINE, 97.0%, 5g

2-Mercapto-4,6-dimethylnicotinonitrile, 95.0%, 5g

4-(4-Bromophenyl)-1-buten-4-ol, 96.0%, 10g

Tabersonine>98.0%(HPLC)(T)250mg